← SynDRA
TRICIRIBINE PHOSPHATE
SynDRA canonical compound SYN0011618 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | AKT1 | AKT2 | AKT3 |
|---|
| Mechanism of action | AKT inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- AKT2 INHIBITOR
- Serine/threonine-protein kinase AKT inhibitor
- AKT3 INHIBITOR
- AKT1 INHIBITOR
- AKT3 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PHKG2
- NQO2
- NTRK1
- NUAK2
- OLA1
- OPA1
- PAICS
- PAK2
- PAK4
- PCYT1A
- PDGFRB
- PDXK
- PEBP1
- PFKP
- PGRMC1
- PIP4K2A
- NEK7
- PIP4K2C
- PKMYT1
- PKN1
- PKN2
- PLK4
- PRKAA1
- PRKACA
- PRKACB
- PRKACG
- PRKAG1
- PRKAR2A
- PRKCA
- PRKCB
- PRKCD
- NEK9
- NEK3
- ABL1
- MARK3
- MAP4K5
- MAPDA
- MAPK1
- MAPK10
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Triciribine
- Triciribina
- Phosphate salt of tricyclic nucleoside
- Vqd-002
- NSC-154020
- NSC-280594
- TCN-P
- UNII-5L5GE3DV88
- Triciribine phosphate [USAN]
- Tricirbine Phosphate
- NSC 280594
- C13H17N6O7P
- Pentaazaacenaphthylene-5' phosphate ester
- 5L5GE3DV88
- PHOSPHATE SALT OF TRICYCLIC NUCLEOSIDE
- 3-Amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)
- Triciribine phosphate (USAN)
- VQD-002
- TCN-monophosphate
- 1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-
- NSC280594
- TCNP
- Tricycloside Phosphate
- RefChem:203200
- DTXCID60133484
- Tricyclic Nucleoside 5'-Phosphate
- SCHEMBL4541
- Triciribine-5'-monophosphate
- Tricyclic nucleoside phosphate
- orb1706005
- SCHEMBL28144885
- SCHEMBL30097342
- GLXC-22304
- BDBM50422306
- EX-A14327
- AKOS030231408
- TRICIRIBINE PHOSPHATE [WHO-DD]
Look up TRICIRIBINE PHOSPHATE in the interactive SynDRA portal →